Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

502
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
502
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

558
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
558
Gastric Emptying01:16

Gastric Emptying

3.2K
Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
3.2K
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

638
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
638
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

2.6K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
2.6K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

738
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
738

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic assessment in older adults with solid tumors: A multicenter comparison of Onco-MPI, Balducci's classification, and G8 score.

Journal of geriatric oncology·2026
Same author

Nationwide Observational Study on the Natural History of Haemodialysis Arteriovenous Access and Patient Survival after Thrombosis in France.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2026
Same author

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026
Same author

Mismatch Between Sensor and Symptoms: The Complex Reality of Hypoglycemia Around Exercise in Type 1 Diabetes Patients Using AID Systems.

Diabetes, obesity & metabolism·2026
Same author

Prevalence and Impact of Disorders of Gut-Brain Interaction in France: Results From the Rome Foundation Global Epidemiology Study.

Neurogastroenterology and motility·2026
Same author

Integrative analysis of circulating biomarkers of colorectal cancer combining mid-infrared spectroscopy and targeted metabolomics.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026

Related Experiment Video

Updated: Jan 5, 2026

Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa
08:17

Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa

Published on: September 27, 2018

8.8K

Gastric Electrical Stimulation Reduces Refractory Vomiting in a Randomized Crossover Trial.

Philippe Ducrotte1, Benoit Coffin2, Bruno Bonaz3

  • 1Rouen University Hospital-Inserm UMR 1073/Inserm CIC-CRB 1404, Rouen, France.

Gastroenterology
|October 25, 2019
PubMed
Summary

Gastric electrical stimulation (GES) effectively reduced refractory vomiting in patients with or without diabetes. However, this treatment did not improve gastric emptying or quality of life in the study participants.

Keywords:
NauseaTherapyTreatmentVomiting

More Related Videos

Author Spotlight: Exploring Abdominal VNS for Inflammatory Conditions
07:17

Author Spotlight: Exploring Abdominal VNS for Inflammatory Conditions

Published on: January 19, 2024

2.7K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.4K

Related Experiment Videos

Last Updated: Jan 5, 2026

Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa
08:17

Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa

Published on: September 27, 2018

8.8K
Author Spotlight: Exploring Abdominal VNS for Inflammatory Conditions
07:17

Author Spotlight: Exploring Abdominal VNS for Inflammatory Conditions

Published on: January 19, 2024

2.7K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.4K

Area of Science:

  • Gastroenterology
  • Medical Devices
  • Clinical Trials

Background:

  • Conflicting results exist regarding the efficacy of gastric electrical stimulation (GES) for refractory vomiting.
  • Gastroparesis often co-occurs with refractory vomiting, complicating treatment options.

Purpose of the Study:

  • To evaluate the efficacy of GES in patients experiencing refractory vomiting, with or without gastroparesis.
  • To assess the impact of GES on vomiting frequency, quality of life, gastric emptying, and diabetes control.

Main Methods:

  • A large, multicenter, randomized, double-blind, crossover trial involving 172 patients with chronic refractory vomiting.
  • Patients received 4 months of active GES followed by 4 months of no stimulation, or vice versa.
  • Primary endpoints included vomiting scores and quality of life (Gastrointestinal Quality of Life Index); secondary endpoints covered digestive symptoms, nutritional status, gastric emptying, and diabetes control.

Main Results:

  • Gastric electrical stimulation (GES) significantly reduced vomiting scores compared to the control (no stimulation) in both diabetic and non-diabetic patients.
  • Vomiting scores improved with GES in patients with both delayed and normal gastric emptying.
  • No significant acceleration of gastric emptying was observed during the active GES period compared to the inactive period.

Conclusions:

  • Gastric electrical stimulation (GES) is effective in reducing the frequency of refractory vomiting in patients with or without diabetes.
  • GES did not demonstrate an ability to accelerate gastric emptying or improve the quality of life in the studied population.
  • Further research may be needed to optimize GES parameters for improving gastric motility and overall patient well-being.